Discontinuation report PUREGON
Report ID | 104641 |
Drug Identification Number | 02242441 |
Brand name | PUREGON |
Common or Proper name | follitropin beta Solution for injection |
Company Name | MERCK CANADA INC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | FOLLITROPIN BETA |
Strength(s) | 100UNIT |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR SUBCUTANEOUS |
Packaging size | 100IU/0.5ML 5X0.5ML |
ATC code | G03GA |
ATC description | GONADOTROPHINS AND OTHER OVULATION STIMULANTS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2020-07-31 |
Actual discontinuation date | 2020-07-31 |
Remaining supply date | 2020-07-31 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-08-01 | English | Compare |
v4 | 2020-07-31 | French | Compare |
v3 | 2020-07-31 | English | Compare |
v2 | 2020-01-28 | French | Compare |
v1 | 2020-01-28 | English | Compare |
Showing 1 to 5 of 5